STABLE LIPOSOMAL FORMULATIONS FOR OCULAR DRUG DELIVERY

PROBLEM TO BE SOLVED: To provide stable liposomal formulations for intraocular drug delivery used for the treatment of ocular hypertension or glaucoma.SOLUTION: This invention provides a therapeutic agent for the treatment of ocular disorder in which prostaglandin F2α such as latanoprost, bimatopros...

Full description

Saved in:
Bibliographic Details
Main Authors SUBRAMANIAN VENKATRAMAN, FREDDY BOEY, TINA HOWDEN, JAYAGANESH V NATARAJAN
Format Patent
LanguageEnglish
Japanese
Published 16.07.2015
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide stable liposomal formulations for intraocular drug delivery used for the treatment of ocular hypertension or glaucoma.SOLUTION: This invention provides a therapeutic agent for the treatment of ocular disorder in which prostaglandin F2α such as latanoprost, bimatoprost, travoprost, or carboprost is encapsulated in the liposome including phosphatidylcholine such as palmitoyl oleoyl phosphatidyl choline. 【課題】高眼圧症または緑内障の治療に用いる薬剤の眼内送達のための安定したリポソーム製剤の提供。【解決手段】ラタノプロスト、ビマトプロスト、トラボプロストまたはカルボプロスト等のプロスタグランジンＦ２αがパルミトイルオレオイルホスファチジルコリンなどのホスファチジルコリンを含むリポソームに封入された眼の障害治療のための治療剤。【選択図】なし
Bibliography:Application Number: JP20140094096